AUXILIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 05334DAA5.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $111,000 | +552.9% | 75,000 | +476.9% | 0.00% | – |
Q3 2014 | $17,000 | -99.4% | 13,000 | -99.5% | 0.00% | -100.0% |
Q2 2014 | $2,941,000 | +111.4% | 2,717,000 | +102.0% | 0.00% | 0.0% |
Q3 2013 | $1,391,000 | +389.8% | 1,345,000 | +357.5% | 0.00% | – |
Q2 2013 | $284,000 | – | 294,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BTG Pactual Global Asset Management Ltd | 7,000 | $18,370,000 | 2.18% |
GLAZER CAPITAL, LLC | 6,500,000 | $8,614,000 | 1.88% |
SILVERBACK ASSET MANAGEMENT LLC | 10,000,000 | $13,210,000 | 1.55% |
CSS LLC/IL | 23,315,000 | $30,884,000 | 1.50% |
Man Investments (CH) AG | 1,900,000 | $2,503,000 | 1.31% |
ANGELO GORDON & CO., L.P. | 9,690,000 | $12,779,000 | 0.84% |
Pinnacle Holdings, LLC | 1,915,000 | $2,541,741,000 | 0.66% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 22,700,000 | $30,065,000,000 | 0.52% |
BASSO CAPITAL MANAGEMENT, L.P. | 2,500,000 | $3,297,000 | 0.50% |
BNP PARIBAS FINANCIAL MARKETS | 3,943,000 | $520,002,848,000 | 0.45% |